Intellia Therapeutics shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.3M | 48k | 27.51 |
| 2023-09-30 | $1.6M | 50k | 31.62 |
| 2023-06-30 | $2.0M | 50k | 40.78 |
| 2023-03-31 | $1.8M | 50k | 36.02 |
| 2022-12-31 | $1.7M | 50k | 34.89 |
| 2022-09-30 | $2.6M | 50k | 52.78 |
| 2022-06-30 | $2.6M | 50k | 51.76 |
| 2022-03-31 | $3.6M | 50k | 72.68 |
More positions owned by Rhenman & Partners Asset Management AB
Cigna Corp (CI)
View all positions for Rhenman & Partners Asset Management AB